Cilo Cybin Holdings Limited (CCC.JO)
Johannesburg · ZAc · Healthcare · Drug Manufacturers - Specialty & Generic
ZAC 145.00 (-3.33%) as of
Key statistics
- Market cap
- 417.73M
- EPS (TTM)
- -0.96
- Dividend yield
- 0.00%
- 52-week range
- 0.70 – 200.00
- Beta
- 0.64
- Revenue (TTM)
- 28.81M
- Profit margin
- 0.00%
- Volume
- 1.00
About Cilo Cybin Holdings Limited
Cilo Cybin Holdings Limited manufactures and sells medical cannabis products in South Africa, Australia, and internationally. The company offers active pharmaceutical ingredients (API) products comprising tetrahydrocannabinol (THC) crude oils, THC distillates, and refined THCs; cannabidiol (CBD) isolate powders, CBD crystal resistant distillates (CRD), CBD crudes, CBD distillates, and CBD-V isolates; and minor cannabinoid products, such as CBN isolates, cannabigerol (CBG) isolates, CBG CRD, CBC isolates, THCV resins, and botanical CBT distillates. It also provides contract manufacturing services for finished cannabinoid products, including oils and tinctures; vape formats; edibles; topicals, including creams, balms, lotions, and other formats; capsules; and secondary packaging, such as labels and batches. In addition, the company operates an online shop for its products. Further, it invests in the biotech, biohacking, and pharmaceutical businesses. Cilo Cybin Holdings Limited was founded in 2018 and is based in Centurion, South Africa.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Centurion, South Africa
- Employees
- 30
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.